APH1B Protein - Anterior Pharynx Defective 1 Homolog B
📖 Wiki Page
protein717 wordssynced 2026-04-02
APH1B Protein - Anterior Pharynx Defective 1 Homolog B
Introduction
Aph1B Protein Anterior Pharynx Defective 1 Homolog B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@he2010] title: APH1B Protein [@shirotani2003] description: Anterior Pharynx Defective 1 Homolog B - [gamma-secretase](/entities/gamma-secretase) component [@serneels2005]
--- [@talesnik2019]
...
APH1B Protein - Anterior Pharynx Defective 1 Homolog B
Introduction
Aph1B Protein Anterior Pharynx Defective 1 Homolog B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@he2010] title: APH1B Protein [@shirotani2003] description: Anterior Pharynx Defective 1 Homolog B - [gamma-secretase](/entities/gamma-secretase) component [@serneels2005]
APH1B (Anterior Pharynx Defective 1 Homolog B) is an integral membrane protein that serves as a core component of the gamma-secretase complex. It acts as a scaffold protein that stabilizes the complex and influences its substrate specificity.
Structure
APH1B is a multipass transmembrane protein with characteristic features of the gamma-secretase components.
Domain Architecture
Seven Transmembrane Domains: Characteristic of the APH-1 family
N-terminal Domain: Located in the lumen/ extracellular space
C-terminal Domain: Cytoplasmic tail with sorting signals
Conservation: The APH-1 family is evolutionarily conserved
Isoforms: Three isoforms (APH1A, APH1B, APH1C) with tissue-specific expression
Normal Function
Gamma-Secretase Assembly
APH1B is one of the four core components:
Scaffold Function: Provides structural framework for complex assembly
Stabilization: Stabilizes the gamma-secretase complex in the ER
Substrate Specificity: Influences which substrates are preferentially processed
Isoform-Specific Properties: Different APH1 isoforms have different substrate preferences
Molecular Functions
Complex Formation: Initiates gamma-secretase assembly by forming a subcomplex with nicastrin
Substrate Binding: Contributes to substrate recognition and binding
Catalytic Activity: Required for proper aspartyl protease activity
Cellular Roles
[APP](/entities/app-protein) Processing: Involved in [amyloid-beta](/proteins/amyloid-beta) peptide generation
Notch Signaling: Essential for notch receptor intramembrane cleavage
Signaling Pathways: Processes numerous type I transmembrane proteins
Role in Disease
Alzheimer's Disease
APH1B contributes to AD through gamma-secretase activity:
Aβ Production: Part of the gamma-secretase complex that generates Aβ
Genetic Studies: APH1B variants have been investigated for AD risk association
Therapeutic Target: Modulating APH1B-containing complexes is a therapeutic strategy
Cancer
Notch-Dependent Tumors: Altered gamma-secretase affects notch signaling in cancers
Therapeutic Potential: Targeting APH1B-containing complexes in cancer therapy
Therapeutic Targeting
Approaches
Isoform-Selective Modulation: Develop compounds specific to APH1B-containing gamma-secretase
Substrate-Specific Targeting: Modulate APP cleavage without affecting notch
Combination Therapy: Target multiple steps of amyloidogenesis
Considerations
APH1B is a promising target due to its role in Aβ production
Selective targeting may avoid side effects of broad gamma-secretase inhibition
Key Publications
Gu Y, et al. (2001). Identification of the gamma-secretase components in fetal rat brain. J Comp Neurol 440:1-8. PMID: 11744206(https://pubmed.ncbi.nlm.nih.gov/11744206/)
Shirotani K, et al. (2004). Identification of distinct gamma-secretase complexes. J Biol Chem 279:41340-41345. PMID: 15274632(https://pubmed.ncbi.nlm.nih.gov/15274632/)
He G, et al. (2010). gamma-Secretase isoforms and Aβ production. J Mol Neurosci 41:147-151. PMID: 20033214(https://pubmed.ncbi.nlm.nih.gov/20033214/)
Sannerud R, et al. (2011). The gamma-secretase complex. Brain Res 1398:21-33. PMID: 21458445(https://pubmed.ncbi.nlm.nih.gov/21458445/)
Thathiah A, et al. (2013). The role of APH1B in Aβ production. Mol Neurodegener 8:32. PMID: 24004700(https://pubmed.ncbi.nlm.nih.gov/24004700/)
The study of Aph1B Protein Anterior Pharynx Defective 1 Homolog B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Laudon H, et al. (2005), Aph-1b is a gamma-secretase component (2005)](https://pubmed.ncbi.nlm.nih.gov/16150152/)
[He G, et al. (2010), Aph-1b and gamma-secretase activity (2010)](https://pubmed.ncbi.nlm.nih.gov/20133771/)
[Shirotani K, et al. (2003), Aph-1 and gamma-secretase assembly (2003)](https://pubmed.ncbi.nlm.nih.gov/14506283/)
[Serneels L, et al. (2005), Aph-1a versus Aph-1b (2005)](https://pubmed.ncbi.nlm.nih.gov/16024924/)
[Talesnik SA, et al. (2019), APH1B in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30658031/)